215 results on '"Rossini, Silvano"'
Search Results
2. Potential selection of unrelated donor based on HLA-DPB1 T-cell epitope matching using data from a single-center analysis
Catalog
Books, media, physical & digital resources
3. SARS-COV-2 screening in allogeneic hematopoietic stem cell donors: Implications for the evaluation process and eligibility
4. Results of the RENAISSANCE Study: REsponse to BNT162b2 COVID-19 vacciNe—short- And long-term Immune reSponSe evAluatioN in health Care workErs
5. Correlation analysis between virtual and Complement-Dependent-Cytotoxicity crossmatch in a monocenter retrospective series of 118 allografted patients
6. The number of HLA confirmatory tests during unrelated donor search as a driver for the evaluation of back-up haploidentical donor(s)
7. Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients
8. Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
9. Correction to: Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
10. Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients.
11. HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia
12. Plasma cell-directed therapy and anti-HLA antibody production: A successful combination?
13. Strong humoral response after Covid‐19 vaccination correlates with the common HLA allele A*03:01 and protection from breakthrough infection.
14. Plasma cell-directed therapy and anti-HLA antibody production: a successful combination?
15. Flow cytometry analysis of lymphocyte subsets in bronchoalveolar lavage: comparison between lung non-Hodgkin lymphomas and reactive diseases
16. Is SARS-CoV-2 screening still necessary before hematopoietic stem cell donation? Observations from a single center and review of the literature
17. Clinical Utility of Fractionating Erythrocytes into 'Percoll' Density Gradients
18. Polymorphism of the HLA system and weak antibody response to BNT162b2 mRNA vaccine
19. Response of steroid-refractory chronic graft-versus-host disease to extracorporeal photopheresis correlates with the dose of CD3+ lymphocytes harvested during early treatment cycles
20. Prognostic relevance of the flow cytometric count of medullar blasts in myelodysplastic syndromes
21. Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study
22. Antibody response to BNT162b vaccine is almost universal in health care workers. Results from the RENAISSANCE study: REsponse to BNT162b2 COVID-19 vacciNe - short And long term Immune reSponSe evAluatioN in healthCare workErs
23. An in Vivo Model of Somatic Cell Gene Therapy for Human Severe Combined Immunodeficiency
24. Temporal, quantitative, and functional characteristics of single-KIR–positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation
25. Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: results of an Italian multicenter study
26. Loss of mismatched HLA in leukemia after stem-cell transplantation
27. New‐Onset Antibodies to Platelet Factor 4 Following Liver Transplantation From a Donor With Vaccine‐Induced Thrombotic Thrombocytopenia
28. Antitumor effects of HSV-TK–engineered donor lymphocytes after allogeneic stem-cell transplantation
29. Frequency and Targeted Detection of HLA-DPB1 T Cell Epitope Disparities Relevant in Unrelated Hematopoietic Stem Cell Transplantation
30. Selective intra-graft apoptosis and down-regulation of lymphocyte bcl-2, iNOs and CD95L expression in kidney–pancreas transplanted patients after anti-Thymoglobulin induction
31. Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes
32. Therapeutic and Diagnostic Applications of Minor Histocompatibility Antigen HA-1 and HA-2 Disparities in Allogeneic Hematopoietic Stem Cell Transplantation: A Survey of Different Populations
33. Mild Course of SARS-CoV-2 Infection in a Liver Transplant Recipient Undergoing Plasma Exchange and Defibrotide for Acute Graft Rejection
34. Platelet transfusion refractoriness in highly immunized beta thalassemia children undergoing stem cell transplantation
35. Expression and modulation of a mononuclear phagocyte differentiation antigen (PAM-1) during in vitro maturation of peripheral blood monocytes
36. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation
37. Acquisition of intact allogeneic human leukocyte antigen molecules by human dendritic cells
38. Clinical relevance of antiplatelet antibodies and the hepatic clearance of platelets in patients with immune thrombocytopenia
39. New‐Onset Antibodies to Platelet Factor 4 Following Liver Transplantation From a Donor With Vaccine‐Induced Thrombotic Thrombocytopenia.
40. A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Extensively Studied by Flow Cytometry and Immunohistochemistry
41. Loss of Suppressor-inducer T-Cells in Chronic-progressive Multiple Sclerosis: Preliminary Results
42. Flow cytometry analysis of lymphocyte subsets in bronchoalveolar lavage: comparison between lung non-Hodgkin lymphomas and reactive diseases
43. Immunological and genotypic analysis of human Tγ-lymphoproliferative disorders
44. Response of steroid‐refractory chronic graft‐versus‐host disease to extracorporeal photopheresis correlates with the dose of CD3+ lymphocytes harvested during early treatment cycles
45. Loss of Suppressor-inducer T-Cells in Chronic-progressive Multiple Sclerosis: Preliminary Results
46. Prognostic relevance of the flow cytometric count of medullar blasts in myelodysplastic syndromes
47. Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells
48. The Challenge Of HSCs Procurement For Gene Therapy: Exploring Plerixafor As Mobilization Agent
49. Plerixafor Single Agent for Autologous Stem Cells Mobilization and Collection in Adult Thalassemic Patients: Towards the Assessment of the Suitable Hematopoietic Stem Cell Source for Gene Therapy of Beta-Thalassemia.
50. Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.